• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌萎缩侧索硬化症评估问卷的简化项目集:ALSAQ-5的开发与验证

Reduced item set for the amyotrophic lateral sclerosis assessment questionnaire: development and validation of the ALSAQ-5.

作者信息

Jenkinson C, Fitzpatrick R

机构信息

Picker Institute Europe, King's Mead House, Oxpens Road, Oxford OX1 1JX, UK.

出版信息

J Neurol Neurosurg Psychiatry. 2001 Jan;70(1):70-3. doi: 10.1136/jnnp.70.1.70.

DOI:10.1136/jnnp.70.1.70
PMID:11118250
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1763474/
Abstract

OBJECTIVE

The 40 item amyotrophic lateral sclerosis assessment questionnaire (ALSAQ-40) is a subjective health measure designed specifically to assess areas of importance to patients with ALS. It was designed for use in surveys and clinical trials of this patient group, and has been assessed for reliability and validity. Despite its relative brevity there are situations where an even shorter form of the instrument would be desirable. Consequently, this paper reports a process of item reduction which results in a brief five item version of the instrument.

METHODS

Data from two surveys of patients with ALS who completed the ALSAQ-40 were analysed to develop a short form ALSAQ. Questionnaire items were correlated with their dimension total scores. Highly correlated items were transformed onto a scale from 0 to 100 and results compared with the parent dimension.

RESULTS

Five items were selected that produced results that closely resembled those of the five dimension scores of the ALSAQ-40.

CONCLUSIONS

Results on the new measure compared with the parent ("gold standard") ALSAQ-40 suggest that the measure can produce similar results to the longer form but with considerable economy.

摘要

目的

40项肌萎缩侧索硬化症评估问卷(ALSAQ - 40)是一种主观健康测评工具,专门用于评估对肌萎缩侧索硬化症患者重要的方面。它设计用于该患者群体的调查和临床试验,并已对其信度和效度进行了评估。尽管它相对简短,但在某些情况下,更简短的版本会更受欢迎。因此,本文报告了一个项目精简过程,最终形成了该问卷的简短五项版本。

方法

对两项完成了ALSAQ - 40的肌萎缩侧索硬化症患者调查数据进行分析,以开发一个简短形式的ALSAQ。问卷项目与其维度总分进行相关性分析。高度相关的项目被转换为0至100的量表,并将结果与原始维度进行比较。

结果

选择了五个项目,其产生的结果与ALSAQ - 40的五个维度得分非常相似。

结论

与原始(“金标准”)ALSAQ - 40相比,新测评工具的结果表明,该测评工具能产生与较长版本相似的结果,但具有显著的经济性。

相似文献

1
Reduced item set for the amyotrophic lateral sclerosis assessment questionnaire: development and validation of the ALSAQ-5.肌萎缩侧索硬化症评估问卷的简化项目集:ALSAQ-5的开发与验证
J Neurol Neurosurg Psychiatry. 2001 Jan;70(1):70-3. doi: 10.1136/jnnp.70.1.70.
2
Comparison of the 40-item Amyotrophic Lateral Sclerosis Assessment Questionnaire (ALSAQ-40) with a short-form five-item version (ALSAQ-5) in a longitudinal survey.在一项纵向调查中,对40项肌萎缩侧索硬化症评估问卷(ALSAQ - 40)与简短的五项版本(ALSAQ - 5)进行比较。
Clin Rehabil. 2007 Mar;21(3):266-72. doi: 10.1177/0269215506071123.
3
Deriving summary indices of health status from the Amyotrophic Lateral Sclerosis Assessment Questionnaires (ALSAQ-40 and ALSAQ-5).从肌萎缩侧索硬化症评估问卷(ALSAQ - 40和ALSAQ - 5)中得出健康状况的汇总指标。
J Neurol Neurosurg Psychiatry. 2003 Feb;74(2):242-5. doi: 10.1136/jnnp.74.2.242.
4
Spanish adaptation of the Amyotrophic Lateral Sclerosis Questionnaire ALSAQ-40 for ALS patients.肌萎缩侧索硬化症患者问卷ALSAQ - 40的西班牙语改编版。
Amyotroph Lateral Scler. 2008 Jun;9(3):168-72. doi: 10.1080/17482960801934072.
5
[Validity and clinical applicability of the Japanese version of amyotrophic lateral sclerosis--assessment questionnaire 40 (ALSAQ-40)].[肌萎缩侧索硬化症日本版评估问卷40(ALSAQ - 40)的有效性及临床适用性]
No To Shinkei. 2004 Jun;56(6):483-94.
6
The Amyotrophic Lateral Sclerosis Assessment Questionnaire (ALSAQ-40): evidence for a method of imputing missing data.肌萎缩侧索硬化症评估问卷(ALSAQ - 40):缺失数据插补方法的证据
Amyotroph Lateral Scler. 2007 Apr;8(2):90-5. doi: 10.1080/17482960600989343.
7
Validity of the Dutch version of the Amyotrophic Lateral Sclerosis Assessment Questionnaire, ALSAQ-40, ALSAQ-5.荷兰版肌萎缩侧索硬化症评估问卷(ALSAQ - 40、ALSAQ - 5)的效度
Amyotroph Lateral Scler. 2007 Apr;8(2):96-100. doi: 10.1080/17482960601012541.
8
The amyotrophic lateral sclerosis assessment questionnaire (ALSAQ-40): tests of data quality, score reliability and response rate in a survey of patients.肌萎缩侧索硬化症评估问卷(ALSAQ - 40):患者调查中的数据质量、评分可靠性及回复率测试
J Neurol Sci. 2000 Nov 1;180(1-2):94-100. doi: 10.1016/s0022-510x(00)00420-2.
9
Development and validation of a short measure of health status for individuals with amyotrophic lateral sclerosis/motor neurone disease: the ALSAQ-40.肌萎缩侧索硬化症/运动神经元病患者健康状况简短测量方法的开发与验证:ALSAQ-40量表。
J Neurol. 1999 Nov;246 Suppl 3:III16-21. doi: 10.1007/BF03161085.
10
Validity and Reliability of the Turkish Version of the Amyotrophic Lateral Sclerosis Assessment Questionnaire.肌萎缩侧索硬化评估问卷土耳其语版的有效性和可靠性。
J Neurosci Nurs. 2019 Oct;51(5):253-258. doi: 10.1097/JNN.0000000000000466.

引用本文的文献

1
Health-Related Quality of Life, Psychological Health, and Patient-Reported Outcomes of Amyotrophic Lateral Sclerosis Patients in China.中国肌萎缩侧索硬化症患者的健康相关生活质量、心理健康及患者报告结局
Brain Sci. 2025 Jun 28;15(7):696. doi: 10.3390/brainsci15070696.
2
Placebo-Controlled, Randomized Double-Blind N-Of-1 Trial to Study Safety and Potential Efficacy of TJ-68 for Improving Muscle Cramps in Patients With Amyotrophic Lateral Sclerosis: A Pilot Study.安慰剂对照、随机双盲N-of-1试验,以研究TJ-68改善肌萎缩侧索硬化症患者肌肉痉挛的安全性和潜在疗效:一项初步研究。
Muscle Nerve. 2025 Sep;72(3):485-492. doi: 10.1002/mus.28459. Epub 2025 Jun 23.
3
Tofersen treatment leads to sustained stabilization of disease in SOD1 ALS in a "real-world" setting.在“真实世界”环境中,托非生治疗可使超氧化物歧化酶1型肌萎缩侧索硬化症(SOD1 ALS)的病情持续稳定。
Ann Clin Transl Neurol. 2025 Feb;12(2):311-319. doi: 10.1002/acn3.52264. Epub 2025 Jan 9.
4
Development of a novel patient reported outcome measure for health-related quality of life in amyotrophic lateral sclerosis (PROQuALS): study protocol.开发一种用于肌萎缩侧索硬化症(PROQuALS)患者健康相关生活质量的新型报告结局测量工具(PROQuALS):研究方案。
Health Qual Life Outcomes. 2024 Aug 30;22(1):69. doi: 10.1186/s12955-024-02286-3.
5
Patient-Reported Outcome Measures in Neuromuscular Diseases: A Scoping Review.神经肌肉疾病患者报告的结局指标:一项范围综述
J Neuromuscul Dis. 2024;11(3):567-577. doi: 10.3233/JND-240003.
6
Randomized double-blind personalized N-of-1 clinical trial to test the safety and potential efficacy of TJ-68 for treating muscle cramps in amyotrophic lateral sclerosis (ALS): study protocol for a TJ-68 trial.随机双盲个体化 N-of-1 临床试验,以测试 TJ-68 治疗肌萎缩侧索硬化症(ALS)肌肉痉挛的安全性和潜在疗效:TJ-68 试验研究方案。
Trials. 2023 Jul 10;24(1):449. doi: 10.1186/s13063-023-07424-8.
7
Assessing the psychometric properties of quality of life measures in individuals with amyotrophic lateral sclerosis: a systematic review.评估肌萎缩侧索硬化症患者生活质量测量工具的心理测量学特性:系统评价。
Qual Life Res. 2023 Sep;32(9):2447-2462. doi: 10.1007/s11136-023-03377-2. Epub 2023 Mar 7.
8
Measurement Properties of Self-Report Questionnaires for Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis of Commonly Used Instruments.肌萎缩侧索硬化症自我报告问卷的测量特性:常用工具的系统评价和荟萃分析。
Int J Environ Res Public Health. 2023 Feb 14;20(4):3310. doi: 10.3390/ijerph20043310.
9
Qualitative measures that assess functional disability and quality of life in ALS.评估 ALS 患者功能障碍和生活质量的定性指标。
Health Qual Life Outcomes. 2022 Jan 21;20(1):12. doi: 10.1186/s12955-022-01919-9.
10
Emotional distress and well-being among people with motor neurone disease (MND) and their family caregivers: a qualitative interview study.运动神经元病患者及其家属的情绪困扰和幸福感:一项定性访谈研究。
BMJ Open. 2021 Aug 17;11(8):e044724. doi: 10.1136/bmjopen-2020-044724.

本文引用的文献

1
Evidence for the validity and reliability of the ALS assessment questionnaire: the ALSAQ-40.肌萎缩侧索硬化症评估问卷(ALSAQ - 40)有效性和可靠性的证据。
Amyotroph Lateral Scler Other Motor Neuron Disord. 1999 Dec;1(1):33-40. doi: 10.1080/146608299300080022.
2
Early diagnosis of dementia: neuroimaging.痴呆的早期诊断:神经影像学
J Neurol. 1999 Jan;246(1):16-20. doi: 10.1007/s004150050300.
3
Methodological approaches to shortening composite measurement scales.缩短复合测量量表的方法学途径。
J Clin Epidemiol. 1997 Mar;50(3):247-52. doi: 10.1016/s0895-4356(96)00363-0.
4
The functional status of patients. How can it be measured in physicians' offices?
Med Care. 1990 Dec;28(12):1111-26.
5
Benefits and obstacles of health status assessment in ambulatory settings. The clinician's point of view. The Dartmouth Primary Care COOP Project.门诊环境中健康状况评估的益处与障碍。临床医生的观点。达特茅斯初级保健合作项目。
Med Care. 1992 May;30(5 Suppl):MS42-9. doi: 10.1097/00005650-199205001-00004.